Related Experiment Video
Updated: Aug 23, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Antiretroviral treatment of maternal HIV infection
Haleh Talaie1, Alejandro A Nava-Ocampo, Gideon Koren
1Hospital for Sick Children, Toronto, Ont.
Question:
One of my pregnant patients tested positive for human immunodeficiency virus. Will HIV therapy put her pregnancy outcome at risk?
Answer:
The biggest risk is vertical transmission of HIV to her baby. She should be treated with combination therapy; triple therapy is required to reduce vertical transmission. Zidovudine is not teratogenic in humans, but information on other antiretroviral drugs is incomplete.
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Virion Maturation and Assembly
Respiratory Syncytial Virus Disease
Cryptococcal Meningitis
Cytomegalovirus Disease
Size and Structure of Viral Genomes

